The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie; Astellas Pharma; Daiichi Sankyo Pharmaceutical; Genentech
Research Funding - Abbvie; Bristol-Myers Squibb; Erasca, Inc; Revolution Medicines; Zentalis
A phase 1/2 dose escalation study of the BCL-2 inhibitor ZN-d5 and the WEE1 inhibitor azenosertib (ZN-c3) in patients (Pts) with acute myeloid leukemia (AML).
 
Catherine Choy Smith
No Relationships to Disclose
 
Pankit Vachhani
Consulting or Advisory Role - Abbvie; Amgen; Blueprint Medicines; CTI BioPharma Corp; Genentech/Roche; Incyte; MorphoSys; Novartis; Pfizer; Stemline Therapeutics
Speakers' Bureau - Incyte
Research Funding - Abbvie (Inst); Amgen (Inst); Astex Pharmaceuticals (Inst); Blueprint Medicines (Inst); Constellation Pharmaceuticals (Inst); CTI BioPharma Corp (Inst); Gilead/Forty Seven (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Seagen (Inst); Takeda (Inst)
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb/Celgene; Curis; Genentech; Gilead Sciences; Novartis
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb
Research Funding - Abbvie; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Curis; Genentech; Gilead Sciences; Novartis
 
Nicole Renee Grieselhuber
No Relationships to Disclose
 
Guru Subramanian Guru Murthy
Honoraria - Cardinal Health; Gilead Sciences; TG therapeutics
Consulting or Advisory Role - Cancer Expert Now; Market Plus; Putnam Associates; Qessential Medical Marketing Research; SmartAnalyst; techspert.io
Research Funding - Xencor
 
Astha Bhatia
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Jatinder Arora
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Hooman Izadi
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Anthony Fiorino
Employment - Zentalis
Stock and Other Ownership Interests - Zentalis
 
Raajit Rampal
Honoraria - Protagonist Therapeutics
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Constellation Pharmaceuticals; CTI BioPharma Corp; Disc Medicine; Galecto; Incyte; Karyopharm Therapeutics; Novartis; Pharmaessentia; Promedior; SERVIER; Sierra Oncology; Stemline Therapeutics; Sunimoto Dainippon; Zentalis
Research Funding - Constellation Pharmaceuticals; Ryvu Therapeutics; Stemline Therapeutics; Zentalis
Travel, Accommodations, Expenses - Incyte; Sierra Oncology